3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Penile Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Metastatic Solid Tumors
1
Melanoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Anus Neoplasms
1
Interventions
Doxorubicin
14
Specimen Handling
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
10
Biopsy
10
Cyclophosphamide
9
X-Rays
7
Radiotherapy
7
Ifosfamide
7
Phantoms, Imaging
6
Nivolumab
6
Gemcitabine
6
tazemetostat
5
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
palbociclib
4
fludarabine
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
larotrectinib
3
cabozantinib
3
atezolizumab
3
Trabectedin
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Ipilimumab
3
Carboplatin
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
bintrafusp alfa protein, human
×
90 days
×
Clear all
No trials found.